BusinessCircleBusinessCircle
  • Home
  • SMEs
  • Startups
  • Markets
  • Finances
  • HR
  • Marketing & Sales
  • Technology
Facebook Twitter Instagram
Friday, May 9
  • About us
  • Advertise with us
  • Submit Articles
  • Privacy Policy
  • Contact us
BusinessCircleBusinessCircle
  • Home
  • SMEs
  • Startups
  • Markets
  • Finances
  • HR
  • Marketing & Sales
  • Technology
Subscribe
BusinessCircleBusinessCircle
Markets

Rivian, Levi Strauss, Biogen, First Solar and more

Business CircleBy Business CircleJuly 10, 2023No Comments2 Mins Read

[ad_1]

A Rivian emblem on an Amazon.com supply electrical van photographed in Chicago, Illinois, on July 21, 2022.

Jamie Kelter Davis | Bloomberg | Getty Pictures

Take a look at the businesses making headlines in noon buying and selling.

Alibaba — U.S. shares of the Chinese language firm added 8.8% in afternoon buying and selling. Earlier on Friday, Reuters first reported that Alibaba’s affiliate firm, Ant Group, would pay a $984 million superb to Chinese language regulators, which might finish a number of years of dispute. Alibaba additionally launched an AI software that may generate photos from textual content prompts.

Rivian Automotive — The electrical automobile maker popped greater than 16% after Wedbush raised its worth goal on shares to $30 from $25, citing an improved outlook. The brand new goal worth implies shares rallying nearly 39% from Thursday’s shut.

Levi Strauss — Shares of the denims maker slumped 6.7% after the corporate minimize its full-year revenue forecast on Thursday. Levi Strauss now expects an adjusted $1.10 to $1.20 per share in comparison with a earlier vary of $1.30 to $1.40.

First Photo voltaic — The photo voltaic firm climbed 4.6% after receiving a five-year revolving line of credit score in addition to a assure for a $1 billion facility. JPMorgan will function the lead arranger for First Photo voltaic.

TG Therapeutics — The pharmaceutical firm soared greater than 10% after Cantor Fitzgerald reiterated an chubby ranking on the inventory. The agency mentioned it sees gross sales of TG Therapeutics’ therapy for relapsing types of a number of sclerosis, Briumvi, to return in above expectations for the second quarter.

Biogen — Shares slipped greater than 2% even after the Meals and Drug Administration authorized its Alzheimer’s therapy, which was developed with Eisai.

DraftKings — The sports activities betting platform added 5% in noon buying and selling. A day earlier, Jefferies included the inventory as one of many shares the agency is forecasting is ready for features as the corporate turns the revenue nook.

— CNBC’s Hakyung Kim and contributed reporting

[ad_2]

Source link

Biogen LEVI Rivian Solar Strauss
Business Circle
  • Website

Related Posts

Biden administration releases draft text of student loan forgiveness

April 16, 2024

Morgan Stanley (MS) earnings Q1 2024

April 16, 2024

How AI Farming Is Already Transforming America

April 16, 2024

Innovative Direct Mail Strategies That Win in Today’s Market

April 16, 2024
Add A Comment

Leave A Reply Cancel Reply

Recent Posts
  • Популярные создатели слотов – кто создает игровые продукты для казино
  • List of most popular given names Wikipedia
  • nlp chatbots 1
  • What’s A Staff Ground Rule Or Staff Working Agreement Agile Practitioners Guide
  • Juegos De Tragamonedas En Casino Con Eth
© 2025 BusinessCircle.co
  • Home
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Type above and press Enter to search. Press Esc to cancel.